BRKR vs QSI
BRKR: Bruker provides advanced analytical and diagnostic technology platforms that enable scientific breakthroughs in life sciences, materials research, and clinical applications. QSI: Quantum-Si is pioneering next-generation single-molecule protein sequencing to democratize access to the proteome and unlock new biological insights.
Side-by-side fundamentals
| Metric | BRKR | QSI | Edge |
|---|---|---|---|
| Price as of 2026-10-20 close | $55.93 | $1.16 | |
| Market cap | $8.5B | $254M | |
| Net margin FY2025, SEC XBRL | -0.3% | -4160.1% | BRKR higher |
| Gross margin FY2025, SEC XBRL | +45.9% | +47.3% | QSI higher |
| Operating margin FY2025, SEC XBRL | +2.0% | -4766.0% | BRKR higher |
| ROE FY2025, SEC XBRL | -0.3% | -46.0% | BRKR higher |
| ROA FY2025, SEC XBRL | -0.1% | -41.3% | BRKR higher |
| Debt / equity filed borrowings, leases excl., balance sheet 2026-06-30 | 0.76 | n/a | |
| Revenue growth (YoY) FY2025, SEC XBRL | +2.1% | -20.3% | BRKR higher |
| Revenue CAGR (3y) SEC XBRL | +10.7% | n/a | |
| Dividend yield as of 2026-09-03 | +0.3% | n/a | |
| Dividend streak (yrs) SEC XBRL | 9 | 0 | BRKR higher |
| Beta as of 2026-09-03 | 1.17 | 2.41 | |
| 1-year return as of 2026-10-20 close | +46.8% | -55.1% | BRKR higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-20.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.